Structure-based design of a dimeric zinc finger protein

被引:50
|
作者
Pomerantz, JL
Wolfe, SA
Pabo, CO
机构
[1] MIT, Dept Biol, Cambridge, MA 02139 USA
[2] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA
关键词
D O I
10.1021/bi972464o
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Designing DNA-binding proteins with novel sequence specificities may provide valuable tools for biological research and gene therapy. Computer modeling was used to design a dimeric zinc finger protein, ZFGD1, containing zinc fingers 1 and 2 from Zif268 and a portion of the dimerization domain of GAL4. ZFGD1 binds with high affinity and specificity to the predicted binding site, which contains two 6 base-pair symmetry-related zinc finger subsites separated by a 13 base-pair spacer, The DNA-binding specificity of this fusion protein is determined primarily by the zinc fingers and can be systematically altered through the substitution of the zinc fingers with variants selected by phage display. This zinc finger-GAL4, fusion may serve as a prototype for designed DNA-binding proteins that could exploit advantages of home-and heterodimer formation, and the adaptability of the Cys(2)His(2) zinc finger motif, to target virtually any site in the genome.
引用
收藏
页码:965 / 970
页数:6
相关论文
共 50 条
  • [31] Structure-based design of a heteromeric transmembrane protein pore.
    Braha, O
    Walker, B
    Cheley, S
    Kasianowicz, J
    Hobaugh, MR
    Song, LZ
    Gouaux, JE
    Bayley, H
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : TUP10 - TUP10
  • [32] Protein structure-based design of anti-protozoal drugs
    Verlinde, CLMJ
    Bressi, JC
    Choe, J
    Suresh, S
    Buckner, FS
    Van Voorhis, WC
    Michels, PAM
    Gelb, MH
    Hol, WGJ
    JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2002, 13 (06) : 843 - 848
  • [33] Structure-based design of chimeric antigens for multivalent protein vaccines
    S. Hollingshead
    I. Jongerius
    R. M. Exley
    S. Johnson
    S. M. Lea
    C. M. Tang
    Nature Communications, 9
  • [34] Contributions of protein structure-based drug design to cancer chemotherapy
    Jackson, RC
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : 164 - 172
  • [35] Protein flexibility:: The ultimate limitation to structure-based drug design?
    Rauh, D
    Günther, J
    Stubbs, MT
    Klebe, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U790 - U790
  • [36] Incorporating protein flexibility into docking and structure-based drug design
    Barril, Xavier
    Fradera, Xavier
    EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (04) : 335 - 349
  • [37] Structure-based drug design
    Stroud, RM
    FASEB JOURNAL, 1997, 11 (09): : A839 - A839
  • [38] Structure-based drug design
    Henry, CM
    CHEMICAL & ENGINEERING NEWS, 2001, 79 (23) : 69 - +
  • [39] Structure-based design of selective histone deacetylase 6 zinc binding groups
    Avelar, Leandro A. Alves
    Ruzic, Dusan
    Djokovic, Nemanja
    Kurz, Thomas
    Nikolic, Katarina
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (11): : 3166 - 3177
  • [40] Assessment of structure-based design
    Kuntz, ID
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 1 - COMP